Filter
1829
Filtered Results: 1829
Text search:
World
Health
Organization,
Regional
Office
South-East
Asia
Featured
Recommendations
170
New Publications
482
Language
Document type
No document type
925
Studies & Reports
422
Guidelines
227
Manuals
98
Strategic & Response Plan
75
Training Material
26
Fact sheets
19
Situation Updates
17
Resource Platforms
11
Infographics
5
Brochures
2
Online Courses
2
Countries / Regions
Global
126
South–East Asia Region
73
India
72
Myanmar / Burma
70
Nepal
49
Asia
46
Bangladesh
35
Philippines
31
Western and Central Europe
29
Indonesia
28
Africa
24
Cambodia
21
Ethiopia
21
Kenya
17
Uganda
17
Syria
14
Tanzania
14
Middle East and North Africa
14
Western Pacific Region
14
Thailand
13
Liberia
13
South Africa
12
Ukraine
11
Eastern Europe
11
Pakistan
11
Ghana
10
Zambia
10
Afghanistan
9
West and Central Africa
9
Sierra Leone
8
Rwanda
8
Nigeria
8
Malawi
8
Latin America and the Carribbean
8
East and Southern Africa
8
Sri Lanka
8
Mozambique
7
Haiti
7
Congo, Democratic Republic of
7
Yemen
7
China
6
Laos
6
Russia
6
South Sudan
6
Senegal
5
Zimbabwe
5
Eastern Europe and Central Asia
5
Sudan
5
Somalia
5
Timor Leste/ East Timor
4
Turkey
4
Venezuela
4
Vietnam
4
Papua New Guinea
4
Moldova
4
North Macedonia
3
Iran
3
Burkina Faso
3
Guinea
3
Jordan
3
Georgia
3
Central African Republic
3
Eswatini/ Swaziland
3
Mexico
2
Kazakhstan
2
Cameroon
2
Albania
2
Malaysia
2
USA
2
Belarus
2
Bosnia and Herzegovina
2
Lebanon
2
Namibia
2
Bhutan
2
Iraq
2
Tajikistan
1
North Korea
1
Colombia
1
Lesotho
1
Canada
1
Singapore
1
Kyrgyzstan
1
Peru
1
Morocco
1
Mongolia
1
Qatar
1
Armenia
1
Guinea-Bissau
1
Croatia
1
Hungary
1
Saudi Arabia
1
Paraguay
1
Gabon
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Tunisia
1
Argentina
1
Brazil
1
Djibouti
1
Egypt
1
Romania
1
Greece
1
Palestine
1
Poland
1
Mali
1
Angola
1
Chad
1
Botswana
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
463
Clinical Guidelines
188
Key Resources
134
Women & Child Health
131
Public Health
130
Capacity Building
38
Pharmacy & Technologies
21
Toolboxes
HIV
180
Mental Health
144
COVID-19
128
Planetary Health
112
TB
86
Rapid Response
79
NTDs
74
AMR
63
Global Health Education
59
Disability
56
Refugee
45
Caregiver
44
NCDs
34
Natural Hazards
33
Health Financing Toolbox
33
Conflict
31
Malaria
28
Zika
21
Pharmacy
20
Ebola & Marburg
17
Polio
12
Cholera
11
Specific Hazards
9
Typhoon
3
Social Ethics
1
En la actualidad, los daños que sufren los pacientes a causa de una atención poco segura constituyen un desafío
importante y creciente para la salud pública mundial y son una de las principales causas de muerte y discapacidad
en todo el mundo. La mayor parte de estos daños son evitables. Ahor...
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
The mhGAP community toolkit: field test version is an integral part of WHO's Mental Health Gap Action Programme (mhGAP), and aims at scaling up services for people with mental health conditions to achieve universal health coverage.
The toolkit provides guidance for programme managers on how to i...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Ahead of World Malaria Day, the WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving the global malaria targets. The strategy outlines 4 strategic objectives ...
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
orientations provisoires, 25 juin 2021. Des tests de diagnostic rapides et précis sont un outil essentiel pour prévenir et contrôler la propagation du COVID-19. Ce document décrit les recommandations relatives aux stratégies nationales de dépistage et à l'utilisation de la PCR et des tests an...
9 March 2022, Timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Ag-RDTs can be performed by individuals in which they collect their own specimen, perform a simple rapid test and interpret their test result themselves at a time a...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
The WHO Guidelines on risk reduction of cognitive decline and dementia provide evidence-based recommendations on lifestyle behaviours and interventions to delay or prevent cognitive decline and dementia. These WHO Guidelines are an important tool for health care providers as well as governments, pol...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Guidelines for national programmes and other stakeholders, for annexes see http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/
